Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies

      Research_and_Markets_Logo

      News provided by

      Research and Markets

      Jun 20, 2023, 06:00 ET

      Share this article

      Share this article


      DUBLIN, June 20, 2023 /PRNewswire/ -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering.

      Globally, there are at least 204 clinical trials focusing on exosome-related studies. Of these, 114 trials are evaluating exosome-based therapeutics and 74 trials are testing exosome-based diagnostic tests.

      Currently, 93 of the exosome trials (45%) are observational studies and 111 of them (55%) are interventional studies. The exosome industry has also achieved two approvals of FDA-approved diagnostic tests: Bio-Techne's ExoDx Prostate IntelliScore Test for prostate cancer and Guardant's 360 CDx test for non-small cell lung cancer.

      To characterize the rapidly expanding exosome market, the analyst has released a 312-page global market report that explores the growing demand for exosome therapeutics, diagnostics, research tools, and manufacturing technologies. The report reveals trend rate data for exosome patents, grants, scientific publications, and clinical trials.

      It highlights information about exosome industry partnerships, merger and acquisition (M&A) activity, and financing events. It features company profiles for 118 global competitors from across the exosome marketplace. Importantly, it presents market size determinations by market segment with forecasts through 2030.

      Exosome technologies have been developing rapidly in recent years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine, and regenerative medicine. In particular, cancer-derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection.

      The cargo contained within exosomes can offer prognostic information for a range of diseases - including cardiovascular, renal, neurodegenerative, and metabolic diseases - as well as cancer. Researchers investigating exosome biomarkers have discovered, identified, and reported the presence of hundreds of biomolecules within the lumen of exosomes. This discovery has compelled a rapid rise in exosome-related cancer biomarker research, including the use of exosomes for the detection, monitoring, and treatment of a diverse range of oncologic conditions.

      Importantly, exosomes are present within a diverse range of biofluids, including serum, plasma, urine, seminal fluid, CSF, saliva, tears, and breast milk. For this reason, exosome-based diagnostics are minimally invasive, offering ease of use and speed of detection. Exosomes can also act as prognostic indicators and predictors of a patient's response to a specific course of treatment.

      Exosomes are also being explored for their use as cell-free therapeutics. For example, if a patient has a disease caused by a missing or defective protein or microRNA, the patient's exosomes can be isolated, modified with the appropriate siRNA or protein, and injected back into the patient for treatment.

      Numerous approaches are being researched for creating drug-loaded exosomes and exosomes themselves can exert powerful effects. For example, mesenchymal stem cell (MSC) derived exosomes have the capacity to suppress inflammation, prevent scar tissue formation, and mediate a healthy immune response.

      For these reasons, exosomes have gone from being overlooked to rapidly gaining momentum as a novel strategy for accessing the therapeutic effects of cells without the risks and difficulties of administering cells to patients. Although exosomes were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits.

      When exosome publications are analyzed, U.S. authors have published approximately 40% of the articles and China comes in second place. When the term "exosome" is searched in the scientific literature, Dr. Susanne Gabrielsson from the Karolinska Institutet in Sweden is the leading author. When the term "extracellular vesicles" is searched, Unicyte AG, a regenerative medicine unit of Fresenius Medical Care, takes the lead. Headquartered in Switzerland, the company has published more than 100 papers on exosomes and extracellular vesicles in combination with Professor Giovanni Camussi.

      To date, three pharma companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have signed partnership deals with exosome companies offering payment terms structured to deliver at or around $1 billion dollars. Within the past 5 years, there have been at least 7 partnership deals within the exosome industry, 8 large venture capital events, and 2 landmark acquisitions.

      Today the exosome industry is witnessing:

      • A surging number of scientific papers investigating exosomes and their applications
      • Rising numbers of clinical trials investigating exosome therapeutics and diagnostics
      • Swelling appetite among investors for exosome technology
      • An increasingly competitive IP environment
      • A diverse range of co-development partnerships
      • Proliferating numbers of exosome competitors in all major life science markets worldwide

      Key Topics Covered:

      1. REPORT OVERVIEW
      1.1 Statement of the Report
      1.2 Target Demographic
      1.3 Report Sources
      1.4 Purpose of the Report
      1.5 Executive Summary
      1.6 Introduction

      2. EXOSOMES: AN OVERVIEW
      2.1 Structure of an Exosome
      2.2 Classification of Exosomes
      2.3 Biomedical Applications of Engineered Exosomes
      2.4 Functions of Exosomes
      2.5 Differences between Exosome Therapy and Cell Therapy
      2.6 Sources of Exosomes for Research
      2.7 Leveraging Exosomes as Biomarkers
      2.8 The Shift from Cell Therapy to Exosome Therapy

      3. EXOSOME ENGINEERING: THE NEW PLATFORM
      3.1 Interior Modification
      3.2 Surface Modifications
      3.3 Comparison of Modification Methods
      3.4 Clinical Applications of Designer Exosomes
      3.5 Companies Developing Engineered Exosome-Based Therapeutics

      4. MSC-DERIVED EXOSOMES IN REGENERATIVE MEDICINE
      4.1 Cardiovascular Diseases
      4.2 Kidney Diseases
      4.3 Liver Diseases
      4.4 Wound Healing
      4.5 MSC Exosome-Based Clinical Trials for Regenerative Medicines

      5. EXOSOME RESEARCH
      5.1 Research to Inhibit Disease-Derived Exosomes
      5.2 Common Isolation Methods in Exosome Research
      5.3 Quality Control (QC) of Exosomes in Exosome Research
      5.4 Bioimaging Modalities used in Exosome Research
      5.5 Labeling Methods used in Exosome Research
      5.6 Determination of Exosome Dose in Exosome Studies
      5.7 Routes of Exosome Administration
      5.8 Characterization of Exosomes in Research

      6. COMMERCIALLY AVAILABLE EXOSOME RESEARCH TOOLS
      6.1 Exosome Capture/Quantification Kits
      6.2 Exosome Standards
      6.3 Immunoplates for Capturing Exosomes
      6.4 Immunobeads for Exosome Isolation
      6.5 Exosome Marker Antibodies

      7. SCIENTIFIC PUBLICATIONS IN EXOSOMES
      7.1 Trends in Global Publications
      7.2 Future in Exosome Research Publications

      8. EXOSOME PATENT LANDSCAPE
      8.1 A Brief Overview of Current Exosome Patent Landscape
      8.2 Leading Assignees of Exosome Patents
      8.3 Exosome Patent/Patent Applications by Geography
      8.4 Legal Status of Exosome Patent/Patent Applications
      8.5 Assignee Categories

      9. EXOSOMES: CLINICAL TRIAL LANDSCAPE
      9.1 Sources of Exosomes used in Clinical Trials
      9.2 Studies using Anti-Tumor Antigens
      9.3 Studies using Cytotoxic Drugs against Cancer
      9.4 Recruitment Status of Ongoing Exosome-based Clinical Trials
      9.5 Study Designs
      9.6 Study Phases
      9.7 Funding Types
      9.8 Exosome Clinical Trials by Geography
      9.9 Clinical Trials Involving MSC-Derived Exosomes
      9.10 Examples of Clinical Trials involving Drug-Loaded Exosomes

      10. CURRENT STATUS OF EXOSOME MANUFACTURING
      10.1 Production of Exosomes from Cell Cultures
      10.2 Production Formats
      10.3 Companies Offering Exosome-Related Services

      11. EXOSOME ISOLATION APPROACHES
      11.1 Differential Ultracentrifugation
      11.2 Ultrafiltration & Sequential Ultrafiltration
      11.3 Size-exclusion Chromatography
      11.4 Polymer Precipitation
      11.5 Immunoaffinity Capture
      11.6 Microfluidics-Based Techniques
      11.7 Commercially Available Exosome Isolation Kits
      11.8 Summary of Different Exosome Isolation Methods
      11.9 Characterization of Exosomes
      11.10 Microscopy and Nanoscopy for Exosome Imaging
      11.11 Direct Post-Isolation Labeling for Imaging
      11.12 Approaches for Exosome Analysis for Gene and Protein Biomarkers
      11.13 Emerging Optical Technologies for Exosome Analysis
      11.14 Emerging Electrochemical and Electromechanical Approaches

      12. DIAGNOSTIC APPLICATIONS OF EXOSOMES
      12.1.1 Exosomal Proteins as Diagnostic Biomarkers
      11.1.2 Exosomal Nucleic Acids as Biomarkers
      12.1.3 Non-Coding RNAs in Exosomes as Biomarkers in Cancers
      12.1.3.1 Exosomes from other Biofluids as Biomarkers for Cancer
      12.2 Exosome Biomarkers in Pregnancy Disorders
      12.3 Exosome Biomarkers and Early Diagnosis of Immunologic Rejection
      12.4 Number of PubMed Articles on Exosome-Based Diagnosis
      12.5 Clinical Trials involving Exosome-based Diagnostics

      13. THERAPEUTIC APPLICATIONS OF EXOSOMES
      13.1 Advantages of Exosomes as Therapeutics
      13.2 Therapeutic Exosome Platforms
      13.3 Drugs Encapsulated in Exosomes
      13.4 Preclinical Studies involving Loaded Exosome Therapeutics
      13.5 Clinical Trials involving Exosome Therapeutics

      14. APPLICATION OF EXOSOMES IN VACCINE DEVELOPMENT
      14.1 Exosome-Based Immunotherapy in Animal Models
      14.2 Ongoing Clinical Trials Involving Exosomes in Developing Vaccines

      15. CURRENT STATUS OF EXOSOME INDUSTRY
      15.1 The Shift from Cell Therapy to Exosome Therapy
      15.2 Clinical Applications of Exosomes
      15.3 Clinical Trials Focusing on Exosome-Based Diagnostics
      15.4 Therapeutic Applications of Exosomes
      15.5 Addreseable Diseases by Exosome Therapeutic Candidates
      15.6 Exosome-Based Vaccine Development
      15.7 Current Status of Exosome-Based Clinical Trials
      15.8 NIH Funding for Exosome Research
      15.9 Deals and Fund Raising in Exosome Space
      15.10 Current Industry Leaders in Exosome Sector
      15.11 The Four Categories of Exosome Companies
      15.12 Current Exosome Technologies by Commercial Companies

      16. EXOSOME MARKET ANALYSIS
      16.1 Market for Exosome Therapeutics
      16.2 The Market for Exosome Diagnostics
      16.3 Market for Exosome Research Products

      17. PROFILES OF EXOSOME MARKET COMPETITORS

      For more information about this report visit https://www.researchandmarkets.com/r/jccllu

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.